News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,930 Results
Type
Article (40444)
Company Profile (253)
Press Release (661233)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204976)
Career Advice (2024)
Deals (35476)
Drug Delivery (96)
Drug Development (81212)
Employer Resources (172)
FDA (16223)
Job Trends (14923)
News (346320)
Policy (32645)
Tag
Academia (2602)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49741)
ALS (88)
Alzheimer's disease (1383)
Antibody-drug conjugate (ADC) (124)
Approvals (16228)
Artificial intelligence (252)
Autoimmune disease (21)
Automation (16)
Bankruptcy (362)
Best Places to Work (11666)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (180)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2251)
Cardiovascular disease (173)
Career advice (1689)
Career pathing (31)
CAR-T (151)
Cell therapy (422)
Cervical cancer (19)
Clinical research (66082)
Collaboration (833)
Compensation (524)
Complete response letters (19)
COVID-19 (2604)
CRISPR (40)
C-suite (242)
Cystic fibrosis (100)
Data (2196)
Decentralized trials (2)
Denatured (18)
Depression (42)
Diabetes (270)
Diagnostics (6398)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86691)
Editorial (36)
Employer branding (21)
Employer resources (146)
Events (112767)
Executive appointments (724)
FDA (17469)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (756)
Gene editing (104)
Generative AI (19)
Gene therapy (302)
GLP-1 (708)
Government (4441)
Grass and pollen (4)
Guidances (59)
Healthcare (18850)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (115)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (314)
IPO (16528)
IRA (40)
Job creations (3667)
Job search strategy (1435)
Kidney cancer (10)
Labor market (38)
Layoffs (470)
Leadership (18)
Legal (7929)
Liver cancer (76)
Lung cancer (320)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (305)
MASH (67)
Medical device (13412)
Medtech (13417)
Mergers & acquisitions (19489)
Metabolic disorders (683)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1917)
NextGen: Class of 2025 (6533)
Non-profit (4509)
Now hiring (39)
Obesity (362)
Opinion (204)
Ovarian cancer (75)
Pain (85)
Pancreatic cancer (83)
Parkinson's disease (149)
Partnered (21)
Patents (233)
Patient recruitment (110)
Peanut (46)
People (57602)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20615)
Phase II (29096)
Phase III (21664)
Pipeline (1185)
Policy (139)
Postmarket research (2568)
Preclinical (8768)
Press Release (68)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5968)
Recruiting (65)
Regulatory (22336)
Reports (46)
Research institute (2363)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (68)
Series A (130)
Series B (85)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3603)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (40)
The Weekly (29)
Vaccines (689)
Venture capitalists (41)
Weight loss (234)
Women's health (35)
Worklife (16)
Date
Today (173)
Last 7 days (870)
Last 30 days (2630)
Last 365 days (32874)
2025 (10618)
2024 (35274)
2023 (40148)
2022 (51254)
2021 (55816)
2020 (54213)
2019 (46703)
2018 (35181)
2017 (32288)
2016 (31678)
2015 (37795)
2014 (31496)
2013 (26573)
2012 (28774)
2011 (29459)
2010 (27561)
Location
Africa (722)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (38096)
Australia (6221)
California (6107)
Canada (2009)
China (521)
Colorado (265)
Connecticut (273)
Delaware (147)
Europe (81747)
Florida (907)
Georgia (206)
Idaho (57)
Illinois (534)
India (25)
Indiana (307)
Iowa (11)
Japan (161)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (890)
Massachusetts (4560)
Michigan (219)
Minnesota (390)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1724)
New Mexico (28)
New York (1739)
North Carolina (967)
North Dakota (8)
Northern California (2668)
Ohio (203)
Oklahoma (14)
Oregon (34)
Pennsylvania (1372)
Puerto Rico (12)
Rhode Island (33)
South America (1105)
South Carolina (22)
South Dakota (1)
Southern California (2293)
Tennessee (103)
Texas (907)
United States (23058)
Utah (180)
Virginia (147)
Washington D.C. (61)
Washington State (551)
West Virginia (3)
Wisconsin (54)
701,930 Results for "saladax biomedical inc sbi".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
Saladax Biomedical, Inc. is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil Assay for sale in Canada in a rapid six days.
May 14, 2024
·
2 min read
Press Releases
Scientific Industries Secures New Funding to Advance its SBI Bioprocessing Division
April 23, 2025
·
3 min read
Press Releases
Groundbreaking New Data on Hologic’s AI-Powered Mammography Technology to Be Presented at SBI
April 24, 2025
·
4 min read
Press Releases
Transpara® Showcases Innovative FDA Cleared Breast AI Capabilities including Breast Density Assessment and Temporal Comparison to Elevate Radiologist Performance at SBI
April 16, 2025
·
3 min read
Press Releases
GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
April 25, 2025
·
8 min read
Press Releases
Impact BioMedical Inc. to Present at The Microcap Conference
January 23, 2025
·
1 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Press Releases
Enigma Biomedical USA, Inc. Announces Candidate Selection of Novel 4R Tau PET Imaging Biomarkers
March 21, 2025
·
2 min read
Deals
Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests
Saladax Biomedical, Inc. is pleased to announce that it has acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV.
April 5, 2022
·
2 min read
Business
Saladax Biomedical, Inc. Announces Global Distribution Agreement With Beckman Coulter, Inc. for Antipsychotic Drug Tests
Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global distribution agreement with Beckman Coulter, Inc. to distribute the MyCare™ Psychiatry Laboratory Assays. The MyCare™ Psychiatry Laboratory Assays measure drug levels of the antipsychotic drugs prescribed to treat patients with serious mental illness (SMI), such as such as Schizophrenia and Bipolar Disorder.
March 15, 2022
·
4 min read
1 of 70,193
Next
